Cookies on this site

The first participant has completed initial study activities and is now randomised to one of the trial’s arms.

A photograph of the chief investigator and research nurses for the LEGEND-D trial © OCDEM
LEGEND-D clinical site research team

The LEGEND-D trial aims to find ways to prevent low blood sugar levels (hypoglycaemia) in type 1 diabetes. It will use  oral diabetic medications, which are normally used to treat type 2 diabetes, in people with type 1 diabetes. Researchers will find out whether administering these medications at smaller doses than normally prescribed could help prevent hypoglycaemia. We will recruit 20 participants with type 1 diabetes and 10 participants without diabetes.

If you are interested in taking part in this trial and wish to know more, please contact the research team at legend-d@ocdem.ox.ac.uk or cru@ocdem.ox.ac.uk.

Similar stories

Type 1 diabetes research centre at University of Oxford marks its first year

Scientists and clinicians are making progress towards a better future for people affected by type 1 diabetes, by exploring how to delay the onset of the condition, develop new treatments, and improve everyday care.

Researchers highlight need for better sleep support for NHS shift workers

A new study led by researchers at the University of Oxford’s Radcliffe Department of Medicine, has found that many NHS staff working shifts experience sleep difficulties, with researchers calling for more accessible, evidence-based support to help staff manage sleep.

Professor Leanne Hodson receives Physiological Society Prize Lecture

The Joan Mott Prize Lecture celebrates women in physiology whose work has demonstrated impact.

Professor Rajesh Thakker receives prestigious William F. Neuman Award

Professor Rajesh Thakker has been named the 2026 recipient of the William F. Neuman Award from the American Society for Bone and Mineral Research (ASBMR), recognising his outstanding scientific contributions to the field.

Heavier drinking linked to higher levels of harmful “hidden” fat, study finds

A study of more than 5,700 adults suggests that higher alcohol consumption is associated with increased levels of visceral fat - the type of fat stored deep inside the abdomen and linked to poorer health outcomes.

Similar stories

Type 1 diabetes research centre at University of Oxford marks its first year

Scientists and clinicians are making progress towards a better future for people affected by type 1 diabetes, by exploring how to delay the onset of the condition, develop new treatments, and improve everyday care.

Researchers highlight need for better sleep support for NHS shift workers

A new study led by researchers at the University of Oxford’s Radcliffe Department of Medicine, has found that many NHS staff working shifts experience sleep difficulties, with researchers calling for more accessible, evidence-based support to help staff manage sleep.

Professor Leanne Hodson receives Physiological Society Prize Lecture

The Joan Mott Prize Lecture celebrates women in physiology whose work has demonstrated impact.

Professor Rajesh Thakker receives prestigious William F. Neuman Award

Professor Rajesh Thakker has been named the 2026 recipient of the William F. Neuman Award from the American Society for Bone and Mineral Research (ASBMR), recognising his outstanding scientific contributions to the field.

Heavier drinking linked to higher levels of harmful “hidden” fat, study finds

A study of more than 5,700 adults suggests that higher alcohol consumption is associated with increased levels of visceral fat - the type of fat stored deep inside the abdomen and linked to poorer health outcomes.